Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 6, 2009
Patent Application Number
10418780
Date Filed
April 16, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds, compositions and methods are provided for modulating the expression of apolipoprotein C-III. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein C-III. Methods of using these compounds for modulation of apolipoprotein C-III expression and for diagnosis and treatment of disease associated with expression of apolipoprotein C-III are provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
